Interview with Dr. Roy Strowd
Why did you feel that it was important to write a book on this topic? What does Neuro-Oncology for the Clinical Neurologist add to the field?
There aren’t many textbooks available for teaching neurologists about neuro-oncology. This book takes a unique case-based approach, and I hope that the patient stories help bring neuro-oncology teaching to life for readers. The book can also be used as a reference: When a healthcare professional is seeing a patient with a tumor- or cancer-related neurological condition, I want them to be able to pick up the book and see how our experts say they would manage the patient and use this to guide their approach.
What is the most exciting aspect of your new publication? What chapter or topic covered are you most excited about?
The entire book is an excellent resource. I’m particularly excited about the chapters on imaging consults: This section of the book is so neat. Each chapter is authored by experts in imaging and patient care, and they walk through their imaging differential diagnosis and open up their brains on how to manage patients who present with various findings on imaging. This section is great for neurologists, internists, oncologists, radiation oncologists, surgeons, or trainees who are sent a patient with an abnormal scan.
Who will find the greatest value from Neuro-Oncology for the Clinical Neurologist?
This book was written with a neurologist or neurology trainee in mind; however, it’s likely to be of great value to trainees in all neuro-oncology-related areas. Oncologists and radiation oncologists in practice may also find value in the sections on inherited tumor syndromes; neurological complications of cancer; chemotherapy, radiation, and immunotherapy; and imaging consults.
What problem do you hope the future generation of neuro-oncology will be able to solve?
Neuro-oncology is really in an era of change – the way we diagnose and classify brain tumors is constantly evolving. I hope to see the book evolve as well, with new editions published in the future to provide clinicians with the latest information as it continues to develop over time.
Roy Strowd, MD, MEd, MS
My name is Roy Strowd – I’m an associate professor of neurology and oncology at the Wake Forest University School of Medicine in Winston Salem, North Carolina. I’m a neuro-oncologist, clinical trialist, and educator. After completing my clinical and research training at Johns Hopkins, I have been practicing at the Comprehensive Cancer Center at Wake Forest University. I specialize in the care of patients with primary brain tumors. I also co-direct the Multidisciplinary Neurofibromatosis Clinic and Comprehensive Tuberous Sclerosis clinics at Wake Forest.
I have a passion for improving the lives of patients with sporadic and inherited nervous system tumors. My research focuses on the development of new drugs to treat patients with brain, spinal cord, and peripheral nerve tumors. I am extremely passionate about developing the next generation of neuro-oncologists, clinicians, and competent leaders in the field. I get most excited when working with teams to bring new knowledge about brain tumors and the neurological care of patients with cancer to trainees, patients, and families.
Outside of the hospital, I spend a lot of time with my family and enjoy playing soccer, snow skiing, beer brewing, and cabinetry.
Leave A Comment